Gen Z wants wellness and enjoyment in home care, Clorox reports
A Clorox report reveals that Gen Z views home care as a source of wellness and enjoyment rather than a chore, influencing how products are designed and marketed. This generation seeks simplicity, versatility, and mental health benefits from cleaning, favoring multi-purpose cleaners and incorporating quick clean-ups into daily routines. Clorox is adapting through new campaigns like "Unleash the Bleach" and rebranding initiatives for products like Fresh Step cat litter, aiming to engage younger consumers by meeting them on social media and addressing their lifestyle preferences.
Zacks Research Has Bearish Forecast for Clorox Q1 Earnings
Zacks Research has issued a bearish forecast for Clorox's (NYSE: CLX) Q1 2027 earnings, lowering their estimate to $1.31 per share and maintaining a "Hold" rating. This comes amidst broader analyst sentiment for Clorox, with an average rating of "Reduce" and a consensus target price of $118.73, despite some firms boosting price targets. The company recently missed Q4 earnings consensus, reporting $1.39 EPS against an estimate of $1.43, and its stock was down 0.9% at market open.
ICICI Prudential Asset Management Co Ltd Has $8.10 Million Stock Holdings in The Clorox Company $CLX
ICICI Prudential Asset Management Co Ltd significantly increased its stake in The Clorox Company by 92.7% in Q3, now holding 65,700 shares valued at $8.10 million. Despite this accumulation, analyst sentiment for Clorox remains cautious, with an average rating of "Reduce" and an average target price of $118.73, citing recent target cuts and negative sentiment from several firms. Other institutional investors like Vanguard Group Inc. and Invesco Ltd. also increased their holdings in Clorox.
The Clorox Company Unveils Home Care Redefined: A Look at How Americans Are Reimagining Time, Wellness, and Convenience at Home
The Clorox Company's "Home Care Redefined" report highlights a significant shift in how Americans approach home care, moving beyond chores to view it as a source of accomplishment, satisfaction, and self-care. The report indicates a rising awareness of home's influence on family health, with younger generations embracing a proactive, wellness-focused approach. Convenience is also evolving, emphasizing ease and enjoyment over mere speed in daily routines.
Why Gen Z actually looks forward to cleaning, per Clorox's new report
The Clorox Company released a new report, "Home Care Redefined," indicating significant shifts in American cleaning habits, wellness perceptions, and convenience preferences. The study reveals that weekly cleaning time has increased to 5.6 hours, with 60% of Americans viewing cleaning as a mood booster, and 49% of Gen Z looking forward to cleaning, compared to 18% of older consumers. These insights highlight a growing consumer focus on health, emotional well-being, and simplified routines in home care.
The Clorox Company Unveils Home Care Redefined: A Look at How Americans Are Reimagining Time, Wellness, and Convenience at Home
The Clorox Company released "Home Care Redefined," a report detailing the evolving landscape of consumer home care. It highlights that Americans are spending more time cleaning, viewing it as a source of accomplishment and well-being, not just chores. The report also notes a shift towards convenience through ease and enjoyment, with younger generations embracing a proactive, wellness-focused approach to home care.
Zacks Research Has Pessimistic View of Clorox Q3 Earnings
Zacks Research has lowered its Q3 2026 earnings per share estimates for Clorox (NYSE:CLX) to $1.48, down from $1.55, maintaining a "Hold" rating on the stock. Other analysts have also adjusted price targets and ratings, resulting in an average "Reduce" rating and a consensus target price of $118.73 for Clorox. The company recently missed Q4 earnings estimates with $1.39 EPS but exceeded revenue expectations at $1.67 billion.
Home Care Has a New Job: Wellbeing
New research from The Clorox Company highlights a significant shift in home care, indicating that cleaning has become more frequent, emotional, and intertwined with personal wellbeing. Americans are spending more time at home, leading to cleaning being viewed as a form of self-care, providing stress relief and a sense of control. This evolution means that the home care industry needs to innovate with solutions that support flexible, intuitive, and emotionally resonant cleaning experiences.
Northeast Investment Management Lowers Holdings in The Clorox Company $CLX
Northeast Investment Management reduced its stake in The Clorox Company (NYSE:CLX) by 20.0%, selling 8,597 shares and holding 34,489 shares valued at $4.25 million. Analysts have a "Reduce" consensus rating with an average target price of $118.73. Insider activity included Director Pierre R. Breber purchasing 4,000 shares, increasing his stake by 44.44% despite the company missing EPS estimates by $0.04.
Fresh Step’s brand refresh simplifies the shelf experience for today’s cat owners
Fresh Step has launched a significant brand refresh to better connect with modern cat parents and strengthen its leadership in the U.S. cat litter market. The refresh focuses on clearer value, improved performance, and a simpler, easier-to-shop portfolio, addressing common pain points like odor control and dust. It includes redesigned packaging, a new jug format for Lightweight litter, and a social-first national campaign titled “Is It Crazy or Is It Love?” to celebrate the unique bond between cats and their owners.
Social-first, creator-led: Clorox and Good Mythical Morning “Unleash the Bleach”
Clorox has partnered with comedy duo Rhett & Link of Good Mythical Morning to launch "Unleash the Bleach," a social-first campaign targeting Zillennials. The campaign utilizes the duo's signature humor in a longform episode of "The Smelling Bee" to make bleach more approachable and culturally relevant. This initiative aligns with Clorox's IGNITE strategy to innovate faster and engage new consumers through creator-led storytelling.
Clorox Co (CLX) Shares Down 3.69% on Feb 17
Shares of Clorox Co (CLX) dropped 3.69% in mid-day trading on February 17, closing at $121.29. This places CLX 23.74% below its 52-week high and 25.48% above its 52-week low. Analysts have an average target price of $123.64 for CLX, suggesting a 1.94% upside, while GuruFocus estimates a fair value of $139.97, implying a 15.4% upside.
Inside P&G’s waterless version of Tide detergent
Procter & Gamble is launching Tide evo, a waterless, plastic-free version of its Tide detergent, nationwide after successful testing in Colorado. This new format, concentrated into dissolvable fiber tiles, is the result of over a decade of development and 50 patents. While more expensive per load than liquid Tide or pods, P&G views it as a significant investment that combines the best features of its existing formats and contributes to its sustainability goals, such as reducing water and plastic consumption, though sustainability is not the primary marketing focus.
3 More Stocks to Invest In Before They’re No Longer Bargains
Morningstar's chief US market strategist Dave Sekera highlighted undervalued stocks. This article discusses three additional stocks—Diageo (DEO), Yum China (YUMC), and Comcast (CMCSA)—that have performed well recently yet are still considered undervalued based on Morningstar's fair value estimates, making them attractive investment opportunities.
What Procter & Gamble (PG)'s Executive Stock Sales After Mixed Earnings Mean For Shareholders
Procter & Gamble's executive chairman and other senior leaders sold significant amounts of PG stock after a mixed fiscal second-quarter earnings report. While the company modestly beat EPS estimates, revenue fell short, leading to analyst commentary on P&G's growth and margin prospects. The article explores how these executive sales and external views shape the investment narrative, emphasizing P&G's ongoing efforts in product innovation and cost discipline amidst risks like input costs and demand volatility.
Clorox fined $14.15M for delayed warning about Pine-Sol bacteria
The Clorox Company has been fined $14.15 million by the U.S. Environmental Protection Agency (EPA) for failing to promptly report a bacterial contamination in certain Pine-Sol cleaning products. This delay led to products linked to serious infections remaining on shelves and being used by consumers. The fine resulted from an investigation that found Clorox did not inform the EPA and consumers about the Mycobacterium fortuitum contamination in a timely manner.
Earnings To Watch: Medifast (MED) Reports Q4 Results Tomorrow
Medifast (NYSE:MED) is set to report its Q4 results soon, with analysts expecting a 40% year-on-year revenue decline to $71.4 million and an adjusted loss of -$0.82 per share. Despite positive sentiment in the personal care segment, Medifast's stock is down 7.6% over the last month, heading into earnings with an average analyst price target of $15. The company met revenue expectations last quarter but has missed Wall Street's revenue estimates three times in the last two years.
Home Care Redefined: A report on how evolving home routines are reshaping modern living
This Clorox report, "Home Care Redefined," explores how evolving home routines are changing people's relationship with home care. It highlights that Americans are prioritizing time, health, and well-being at home, leading to shifts in cleaning habits, increased awareness of the home environment's impact on health, and a preference for convenience that eases friction rather than merely speeding up tasks. The report aims to help meet consumers' changing needs in the home care space.
Clorox Declares Regular Quarterly Dividend of $1.22 Per Share
The Clorox Company announced that its board of directors has declared a quarterly dividend of $1.22 per share on the company's common stock. This dividend is payable on November 7, 2024, to shareholders of record as of October 23, 2024. Clorox highlighted its consistent history of delivering shareholder value through regular dividend payments and annual increases.
Can Clorox (CLX) Sustain Its Transformation While Raising Dividends and Integrating Purell?
Clorox recently reported a slight dip in Q2 sales and net income but reaffirmed its full-year earnings guidance, maintaining its dividend streak and continuing a complex business transformation, including an ERP rollout and integrating the Purell acquisition. The company's investment narrative hinges on its ability to weather weak category growth and consumer trading down, with a focus on margin recovery as ERP disruption fades. Despite these efforts, analysts remain divided on its future prospects and fair value.
Proctor (PG)'s a Machine Despite Slow Growth, Says Jim Cramer
Jim Cramer describes Procter & Gamble (NYSE:PG) as a "machine" despite its slow organic growth. The company's shares are down 6% over the past year but up 13% year-to-date. Analysts have issued mixed ratings, with some noting sluggish organic sales growth but potential for fundamental improvement.
Clorox fined $14.15M for delayed warning about Pine-Sol bacteria
Clorox has been fined $14.15 million by the Consumer Product Safety Commission (CPSC) for failing to promptly report bacterial contamination in some of its Pine-Sol cleaning products. The contamination, which included species of Pseudomonas bacteria, led to a recall of 37 million bottles. The CPSC stated Clorox delayed reporting for about two years after discovering the issue.
Illinois Municipal Retirement Fund Sells 33,875 Shares of The Clorox Company $CLX
The Illinois Municipal Retirement Fund significantly reduced its stake in The Clorox Company by selling 33,875 shares, lowering its holdings to 54,378 shares valued at $6.7 million. This move comes amidst other institutional investors making smaller adjustments to their positions, while Clorox Director Pierre R. Breber increased his ownership by purchasing 4,000 shares. Clorox recently reported quarterly EPS of $1.39, missing estimates, and announced a quarterly dividend of $1.24.
Envestnet Asset Management Inc. Sells 139,575 Shares of The Clorox Company $CLX
Envestnet Asset Management Inc. significantly reduced its stake in The Clorox Company (NYSE:CLX) by 43.9% in the third quarter, selling 139,575 shares. Despite this, a Clorox director acquired 4,000 shares, increasing his holdings. Analyst ratings are generally cautious, with a consensus "Reduce" rating and an average price target of $118.07, and the company recently missed its quarterly earnings estimate.
Amid Intensifying Competition, We Think Clorox Wisely Favors Boosting Its Edge With Brand Spending
Morningstar analyst Erin Lash believes Clorox is wisely investing in its brand mix to maintain its competitive edge amidst intensifying competition and various industry headwinds, such as supply chain issues, inflation, and a cyberattack. The company's focus on brand spending, even with increased promotional activity in some categories, is seen as a prudent strategy to ensure the long-term health and competitiveness of its business.
Clorox Acquisition Of GOJO Tests Margins Valuation And Dividend Resilience
Clorox recently acquired GOJO Industries for $2.25 billion and completed a major ERP system implementation, while navigating ongoing operational and margin pressures. These strategic moves add complexity for Clorox, which is also maintaining its long-standing dividend payments. Investors should monitor how effectively Clorox integrates GOJO, manages costs, and restores profitability, especially given the company's valuation and current debt levels.
Clorox fined $14.15M for delayed warning about Pine-Sol bacteria
Clorox has been fined $14.15 million for failing to promptly report a defect in its Pine-Sol cleaners that led to bacterial contamination. The company received hundreds of complaints about mold and mildew in bottles before issuing a recall or adequately informing regulators, resulting in injuries and property damage. This penalty highlights the importance of timely reporting of product safety issues.
Clorox Balances Purell Deal And ERP Overhaul As Margins Squeezed
Clorox recently completed a $2.25 billion acquisition of GOJO Industries, the maker of Purell, significantly expanding its health and hygiene portfolio. Concurrently, the company finalized a $580 million ERP system implementation that has previously caused operational disruptions and margin pressure. Investors are now watching how Clorox integrates GOJO and stabilizes its operations to improve sales and net income following these major strategic initiatives.
Clorox’s 5% Yield Dominates Consumer Staples: Can It Continue?
Clorox (CLX) recently paid a $1.24 per share dividend, extending its 48-year streak of increases, resulting in a 4.07% yield despite operational turbulence and margin pressures. While cash flow coverage has improved from a concerning 2024, the company faces challenges including compressed gross margins due to consumers trading down, and efficiency disadvantages compared to peers like P&G. The premium yield reflects investor skepticism about Clorox's near-term prospects, contingent on successful execution of margin expansion and a return to volume growth.
Wealthfront Advisers LLC Boosts Position in The Clorox Company $CLX
Wealthfront Advisers LLC significantly increased its stake in The Clorox Company by 93.8% in Q3, now holding 55,981 shares valued at approximately $6.90 million. Additionally, Director Pierre R. Breber boosted his ownership by 44.44% through a direct purchase of 4,000 shares. Despite a consensus "Reduce" rating from analysts with an average target price of $117.93, Clorox announced a quarterly dividend of $1.24 per share.
P&G Rallies Under New CEO but Lags Rivals, Faces Tariff Challenges
Procter & Gamble (PG) has seen its stock rise 11.65% year-to-date, but this growth lags behind competitors like Clorox, Colgate-Palmolive, and Church & Dwight in the consumer staples sector. The company, under new CEO Shailesh Jejurikar, faces significant challenges including $900 million in tariff headwinds and projected fiscal 2026 organic sales growth of flat to 3%, lower than analyst expectations. Despite its premium valuation and status as a Dividend Aristocrat appealing to income investors, P&G's growth outlook appears questionable due to these pressures and its underperformance compared to peers.
Clorox fined $14.15M for delayed warning about Pine-Sol bacteria
The article reports that Clorox has been fined $14.15 million by the U.S. Consumer Product Safety Commission (CPSC). This penalty is for their failure to promptly report a defect in Pine-Sol cleaners that led to bacterial contamination and recalls. Clorox waited several months before notifying the CPSC, despite being aware of issues causing bacterial growth and related illnesses.
Q2 Deep Dive: Evaluating Clorox's Financial and Operating Metrics
The Clorox Company (CLX) reported mixed Q2 fiscal 2026 results, with adjusted earnings missing estimates but net sales surpassing expectations. While overall sales and organic sales declined year-over-year, the International and Health and Wellness segments showed strength. However, the Household and Lifestyle segments experienced sales declines, influenced by a volatile macroeconomic environment and ERP implementation challenges.
Clorox (NYSE:CLX) Raised to Neutral at BNP Paribas Exane
BNP Paribas Exane upgraded Clorox (NYSE:CLX) from an "underperform" to a "neutral" rating. Despite this upgrade, the consensus among analysts remains a "Reduce" with an average price target of $117.93, while the stock currently trades around $121.47. Clorox recently reported a slight EPS miss but revenue that modestly beat estimates, though it was down year-over-year.
Winners And Losers Of Q4: Colgate-Palmolive (NYSE:CL) Vs The Rest Of The Household Products Stocks
This article analyzes the Q4 performance of several household products stocks, contrasting Colgate-Palmolive's results with those of peers like Spectrum Brands, WD-40, Central Garden & Pet, and Clorox. It highlights that while the sector saw mixed results, overall revenues beat estimates, and share prices have been resilient. Colgate-Palmolive reported strong growth, exceeding analyst expectations, while Spectrum Brands also performed well.
Frontdoor Celebrates National Home Warranty Day on February 10
Frontdoor, Inc. is celebrating National Home Warranty Day on February 10th to emphasize the importance of home warranties in protecting homeowners from unexpected repair costs and providing financial security. The company highlights its extensive service network, including American Home Shield and 2-10 Home Buyers Warranty, which connects homeowners with independent contractors nationwide. Analyst views on FTDR indicate a positive outlook, with an average 1-year price target of $67.00.
Winners And Losers Of Q4: Colgate-Palmolive (NYSE:CL) Vs The Rest Of The Household Products Stocks
This article analyzes the Q4 performance of Colgate-Palmolive (NYSE:CL) and other household products stocks, noting the industry's general stability and growing emphasis on eco-friendly products. Colgate-Palmolive exceeded revenue and EBITDA estimates, while Spectrum Brands also had a strong quarter. WD-40 missed EPS and EBITDA estimates but saw its stock rise, and Central Garden & Pet underperformed analysts' expectations for revenue and EBITDA.
Clorox's Q4 Earnings Call: Our Top 5 Analyst Questions
Clorox's Q4 earnings reported flat year-on-year sales, missing analyst EPS expectations, primarily due to ERP rollout disruptions and increased promotional activities impacting margins. CEO Linda Rendle and CFO Luc Bellet addressed analyst questions on competitive intensity, new product launches, gross margin outlook, pricing strategies, and the integration of Gojo. Key catalysts for future quarters include new product uptake, margin improvements, and the strategic impact of the Gojo integration.
Are Wall Street Analysts Bullish on Clorox Stock?
The Clorox Company (CLX) has underperformed the broader market and the consumer staples sector over the past 52 weeks but has seen a significant YTD uptick. Analysts maintain a consensus "Hold" rating, with a recent price target from Morgan Stanley suggesting a potential upside. Despite a mixed Q2 earnings report, the configuration of analyst ratings has become less bearish.
Pediatrix Medical Group to Host Investor Conference Call
Pediatrix Medical Group (MD) will host an investor conference call on February 19, 2026, at 9:00 a.m. ET to discuss its operational results for the quarter ended December 31, 2025. The call will be webcasted via the company's website and will provide crucial financial and operational insights. Analysts currently forecast a 1-year average price target of $23.50 for MD, with a "Moderate Buy" consensus based on recent upgrades.
Can Pricing and Mix Sustain Procter & Gamble's Margin Strength?
Procter & Gamble is effectively using strategic pricing, premiumization, and innovation to defend its margins against rising costs and sustain demand. The company's focus on passing through cost increases selectively and leveraging productivity savings has helped offset a decline in core gross margin. Despite macro headwinds, these strategies, along with continuous product innovation and supply-chain efficiencies, are expected to continue supporting growth and margin strength, although the stock currently holds a Zacks Rank #4 (Sell).
ProShare Advisors LLC Boosts Stake in The Clorox Company $CLX
ProShare Advisors LLC significantly increased its holdings in The Clorox Company by 11.7% in Q3, now owning 1,297,016 shares valued at approximately $159.9 million. This increase comes amid cautious sell-side sentiment with a "Reduce" consensus rating, although some analysts have raised price targets. Clorox recently reported mixed Q2 results, missing EPS estimates but reaffirming its 2026 outlook, and continues to offer a strong dividend yield of 4.1%.
The Clorox Company $CLX Shares Sold by Nuance Investments LLC
Nuance Investments LLC decreased its stake in The Clorox Company (CLX) by 18.1% in the third quarter, though the stock remains its largest holding. Analysts largely maintain a cautious "Reduce" rating with a consensus price target of $117.93, following mixed Q2 results that included a slight EPS miss and flat revenue. Despite concerns, Clorox pays a quarterly dividend of $1.24 per share, yielding approximately 4.1%.
Allianz Asset Management GmbH Reduces Holdings in The Clorox Company $CLX
Allianz Asset Management GmbH reduced its stake in The Clorox Company (CLX) by 19.6% in Q3, selling 27,498 shares and retaining 112,951 shares valued at approximately $13.93 million. This comes as Clorox reported mixed Q2 results, with a slight EPS miss and analysts giving a consensus "Reduce" rating with a price target of $117.93, while also noting positive sentiment from some investors and a director's recent share purchase. The company recently announced a quarterly dividend of $1.24 per share, representing a 4.1% yield.
Fresh Step and Ariana Madix challenge singles to “date cats, not humans” this Valentine’s Day
Fresh Step has partnered with Ariana Madix and Best Friends Animal Society for a Valentine's Day campaign titled "Date Cats, Not Humans," encouraging cat adoption. This initiative, part of Fresh Step's brand refresh, highlights the positive attributes of cat ownership, including improved trust and romantic compatibility, and offers free adoption fees and a month of free litter to new adopters. The campaign aims to boost adoption efforts and strengthen emotional connections with pet owners.
Clorox fined $14.15M for delayed warning about Pine-Sol bacteria
Clorox has been fined $14.15 million by the U.S. Consumer Product Safety Commission (CPSC) for failing to promptly report that certain Pine-Sol products were contaminated with bacteria. The contamination, which included Pseudomonas aeruginosa, led to a recall of 37 million bottles. The CPSC stated that Clorox was aware of the issue for months before notifying the agency, potentially endangering immunocompromised individuals.
Clorox (CLX) Is Consistent, Says Jim Cramer
Jim Cramer highlighted The Clorox Company (CLX) as a consistent performer, noting its stability despite not offering significant growth. Recent analyst upgrades from Wells Fargo and JPMorgan increased price targets for CLX, citing its acquisition of the Purell hand sanitizer manufacturer. The company's latest earnings report showed a revenue beat but an earnings-per-share miss.
Clorox (CLX) Is Consistent, Says Jim Cramer
Jim Cramer highlighted The Clorox Company (CLX) as a consistent performer, despite its shares being down 19% over the past year but up 18% year-to-date. Both Wells Fargo and JPMorgan recently raised their price targets for Clorox, acknowledging its acquisition of the Purell manufacturer and its stable operations. While Clorox's latest earnings missed analyst estimates, revenue surpassed expectations, reinforcing its image as a reliable, albeit not rapidly growing, business.
Clorox (NYSE:CLX) Rating Increased to Hold at Wall Street Zen
Wall Street Zen upgraded Clorox (NYSE:CLX) from a "sell" to a "hold" rating. This adjustment comes amidst varied analyst opinions, with several firms maintaining "hold" or "neutral" ratings, and a consensus "Reduce" rating from MarketBeat data. Clorox recently missed quarterly EPS estimates but exceeded revenue expectations, and the article details financial performance, insider activity, and institutional investor movements.
Willis Investment Counsel Boosts Position in The Clorox Company $CLX
Willis Investment Counsel increased its stake in The Clorox Company (NYSE:CLX) by 4.3% in the third quarter, bringing its total holdings to 232,400 shares valued at $28.66 million. Other hedge funds also adjusted their positions, and institutional investors now own 78.53% of the company's stock. Clorox recently reported quarterly earnings that missed analyst estimates despite higher-than-expected revenue, and the stock's performance and analyst ratings have seen mixed sentiment.
